Press Releases Sunshine Biopharma, Inc.

Equities

SBFM

US8677816014

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
0.742 ^USD	-7.52%		-16.63%	-97.27%

May. 21	Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M	MT
May. 20	Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta	Apr. 22	AQ
Sunshine Biopharma Announces Reverse Stock Split	Apr. 15	AQ
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?	Mar. 06	PR
Sunshine Biopharma Moves Principal Office to New York City	Dec. 04	AQ
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%	23-08-11	AQ
SUNSHINE BIOPHARMA, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	23-05-16	AQ
Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market	23-05-16	AQ
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market	23-05-12	AQ
SUNSHINE BIOPHARMA, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%	23-05-11	AQ
Sunshine Biopharma : Certificate of Incorporation/Bylaws - Form 8-K	23-04-19	PU
SUNSHINE BIOPHARMA, INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-04-19	AQ
Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update	23-04-05	AQ
SUNSHINE BIOPHARMA, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-04	AQ
SUNSHINE BIOPHARMA, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-03-24	AQ
Vivakor Announces New Board of Directors	23-03-23	AQ
Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment	23-02-28	AQ
SUNSHINE BIOPHARMA, INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-02-28	AQ
SUNSHINE BIOPHARMA, INC : Other Events (form 8-K)	23-02-13	AQ
SUNSHINE BIOPHARMA SIGNS RESEARCH AGREEMENT WITH THE JEWISH GENERAL HOSPITAL TO ADVANCE THE DEVELOPMENT OF Adva-27a ANTICANCER COMPOUND	23-02-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sunshine Biopharma, Inc.

Equities

SBFM

US8677816014

Press Releases

Filters